Drug Res (Stuttg) 2021; 71(07): 379-387
DOI: 10.1055/a-1389-5499
Original Article

Lansoprazole a Proton Pump Inhibitor Prevents IBD by Reduction of Oxidative Stress and NO Levels in the Rat

Tejal Gandhi
Department of Pharmacology, Anand Pharmacy College, Anand, Gujarat India
,
Anish Sharma
Department of Pharmacology, Anand Pharmacy College, Anand, Gujarat India
,
Navdha Vyas
Department of Pharmacology, Anand Pharmacy College, Anand, Gujarat India
,
Parth Gupta
Department of Pharmacology, Anand Pharmacy College, Anand, Gujarat India
,
Mihir Parikh
Department of Pharmacology, Anand Pharmacy College, Anand, Gujarat India
,
Hital Shah
Department of Pharmacology, Anand Pharmacy College, Anand, Gujarat India
› Author Affiliations
Acknowledgment: No funding was received for this manuscript. This is an Anand Pharmacy College communication.

Abstract

The inflammatory disease’s increased prevalence leads to a major concern around the world. Still, there is a lack of effective and successful therapy in the reversal of Inflammatory Bowel Disease (IBD) symptoms. Whereas, reactive oxygen species (ROS) production and muddled defense capacity of antioxidants in IBD subjects reported several times. Many proton pump inhibitors have been reported previously for their anti-inflammatory effect. The present study is aimed to assess the ameliorative effect of lansoprazole in experimentally induced IBD in rats. Thirty-six female Sprague Dawley rats were divided equally into six groups based on their body weight. Lansoprazole (1, 5, and 10 mg/kg, p.o.) and 5-aminosalicylate (5-ASA, 100 mg/kg, p.o.) served as standard control respectively, given for 18 days once a day. On the 11th day of the study, colitis was induced by intrarectal instillation of 2, 4-Dinitrobenzene sulfonic acid (DNBS), and treatment was continued for the next 7 days. Administration of lansoprazole (at 5 and 10 mg/kg) significantly reduced DAI (Disease Activation Index) and CMDI (Colon Macroscopic Damage Index); which further justifies a reduction in colon inflammation grades, as well as histopathological changes, and reflected by the stalling of body weight. The anti-inflammatory effects were indicated by lowered MPO (myeloperoxidase) and SOD (superoxide dismutase) in colon tissue as well as restores colonic NO (nitric oxide) level. The study shows lansoprazole improved DAI and CMDI scores, reduction of neutrophil infiltration, and an improved antioxidant status indicating an anti-ulcerative effect in DNBS-induced experimental colitis that is comparable with 5-ASA treatment.



Publication History

Received: 06 December 2020

Accepted: 08 February 2021

Article published online:
16 March 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Bergmann M, Hernandez V, Bernigau W. et al. No association of alcohol use and the risk of ulcerative colitis or Crohn’s disease: Data from a European Prospective cohort study (EPIC). European Journal of Clinical Nutrition 2017; 71: 512-518
  • 2 Asdell SA. Comparative chronologic age in man and other mammals. Journal of Gerontology 1946; 1: 224-236
  • 3 Mi H, F-b Liu, H-w Li. et al. Anti-inflammatory effect of Chang-An-Shuan on TNBS-induced experimental colitis in rats. BMC Complementary and Alternative Medicine 2017; 17: 1-8
  • 4 Sartor RB. Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nature clinical practice Gastroenterology & Hepatology 2006; 3: 390-407
  • 5 Yao J, Wang J-Y, Liu L. et al. Anti-oxidant effects of resveratrol on mice with DSS-induced ulcerative colitis. Archives of Medical Research 2010; 41: 288-294
  • 6 Khairy H, Saleh H, Badr AM. et al. Therapeutic efficacy of osthole against dinitrobenzene sulphonic acid induced-colitis in rats. Biomedicine & Pharmacotherapy 2018; 100: 42-51
  • 7 Bribi N, Algieri F, Rodriguez-Nogales A. et al. Intestinal anti-inflammatory effects of total alkaloid extract from Fumaria capreolata in the DNBS model of mice colitis and intestinal epithelial CMT93 cells. Phytomedicine 2016; 23: 901-913
  • 8 El-Abhar HS, Hammad LN, Gawad HSA. Modulating effect of ginger extract on rats with ulcerative colitis. Journal of Ethnopharmacology 2008; 118: 367-372
  • 9 Abdallah DM, Ismael NR. Resveratrol abrogates adhesion molecules and protects against TNBS-induced ulcerative colitis in rats. Canadian Journal of Physiology and Pharmacology 2011; 89: 811-818
  • 10 Liu X, Wang J. Anti-inflammatory effects of iridoid glycosides fraction of Folium syringae leaves on TNBS-induced colitis in rats. Journal of Ethnopharmacology 2011; 133: 780-787
  • 11 Londong W, Barth H, Dammann H. et al. Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazole. Alimentary Pharmacology & Therapeutics 1991; 5: 245-254
  • 12 Satoh H, Inatomi N, Nagaya H. et al. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats. Journal of Pharmacology and Experimental Therapeutics 1989; 248: 806-815
  • 13 Rai K, Matsui H, Kaneko T. et al. Lansoprazole inhibits mitochondrial superoxide production and cellular lipid peroxidation induced by indomethacin in RGM1 cells. Journal of Clinical Biochemistry and Nutrition 2011; 49: 25-30
  • 14 Arnold R. Safety of proton pump inhibitors–an overview. Alimentary Pharmacology & Therapeutics 1994; 8: 65-70
  • 15 Lai K-C, Chu K-M, Hui W-M. et al. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. The American Journal of Medicine 2005; 118: 1271-1278
  • 16 Hoshino E, Umeda N, Sano J. et al. Lansoprazole for maintenance therapy of peptic ulcer disease: weekend full-dose or everyday half-dose administration?. Journal Ocal Gastroenterology 1995; 20: S72-S74
  • 17 Kedika RR, Souza RF, Spechler SJ. Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Digestive Diseases and Sciences 2009; 54: 2312-2317
  • 18 Sandhu DS, Fass R. Current Trends in the Management of Gastroesophageal Reflux Disease. Gut and Liver 2018; 12: 7-16
  • 19 Moayyedi P, Eikelboom JW, Bosch J. et al. Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin. Gastroente 2019; 157: 682-91. e2
  • 20 Johari S, Joshi C, Gandhi T. Effect of Cyperus Rotundus on cytokine gene expression in experimental inflammatory bowel disease. Iranian Journal of Medical Sciences 2016; 41: 391
  • 21 Murano M, Maemura K, Hirata I. et al. Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clinical and Experimental Immunology 2000; 120: 51-58
  • 22 Wallace JL, Keenan CM. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am J Physi 90 258: G527-G534
  • 23 Joshi SV, Vyas BA, Shah PD. et al. Protective effect of aqueous extract of Oroxylum indicum Linn. (root bark) against DNBS-induced colitis in rats. Indian Journal of Pharmacology 2011; 43: 656-661
  • 24 Sykes AP, Bhogal R, Brampton C. et al. The effect of an inhibitor of matrix metalloproteinases on colonic inflammation in a trinitrobenzenesulphonic acid rat model of inflammatory bowel disease. Aliment Pharmacol Ther 1999; 13: 1535-1542
  • 25 Krawisz J, Sharon P, Stenson W. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity: assessment of inflammation in rat and hamster models. Gastroenterology 1984; 87: 1344-1350
  • 26 Gasparovic AC, Jaganjac M, Mihaljevic B. et al. Assays for the measurement of lipid peroxidation. Cell Senescence. Springer; 2013: 283-296
  • 27 Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. Journal of Biological Chemistry 1972; 247: 3170-3175
  • 28 Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric oxide: Biology and Chemistry 2001; 5: 62-71
  • 29 Biswas K, Bandyopadhyay U, Chattopadhyay I. et al. A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. Journal of Biological Chemistry 2003; 278: 10993-11001
  • 30 Zedtwitz-Liebenstein K, Wenisch C, Patruta S. et al. Omeprazole treatment diminishes intra-and extracellular neutrophil reactive oxygen production and bactericidal activity. Critical Care Medicine 2002; 30: 1118-1122
  • 31 Noble DW. Proton pump inhibitors and stress ulcer prophylaxis: pause for thought?. Critical Care Medicine 2002; 30: 1175-1176
  • 32 Yoda Y, Amagase K, Kato S. et al. Prevention by lansoprazole, a proton pump inhibitor, of indomethacin-induced small intestinal ulceration in rats through induction of heme oxygenase-1. Journal of Physiology and Pharmacology 2010; 61: 287
  • 33 Schulz-Geske S, Erdmann K, Wong RJ. et al. Molecular mechanism and functional consequences of lansoprazole-mediated heme oxygenase-1 induction. World Journal of Gastroenterology 2009; 15: 4392-4401
  • 34 Ichikawa H, Yoshida N, Takagi T. et al. Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats. World Journal of Gastroenterology: WJG 2004; 10: 2814
  • 35 Wilcox GM, Mattia A. Collagenous colitis associated with lansoprazole. Journal of Clinical Gastroenterology 2002; 34: 164-166
  • 36 Thomson RD, Lestina LS, Bensen SP. et al. Lansoprazole-associated microscopic colitis: A case series. The American Journal of Gastroenterology 2002; 97: 2908-2913
  • 37 Watanabe T, Hirakawa K, Sato S. et al. A case with collagenous colitis and multiple longitudinal ulcers. Gastroenterological Endoscopy 2008; 50: 27-33
  • 38 Blau S, Kohen R, Bass P. et al. Relation between colonic inflammation severity and total low-molecular-weight antioxidant profiles in experimental colitis. Digestive Diseases and Sciences 2000; 45: 1180-1187
  • 39 Morampudi V, Bhinder G, Wu X. et al. DNBS/TNBS colitis models: providing insights into inflammatory bowel disease and effects of dietary fat. JoVE (Journal of Visualized Experiments) 2014; e51297
  • 40 Barone M, Chain F, Sokol H. et al. A Versatile New Model of Chemically Induced Chronic Colitis Using an Outbred Murine Strain. Frontiers in microbiology 2018; 9: 565
  • 41 Abu-Gharbieh E, Bayoumi FA, Ahmed NG. Alleviation of antioxidant defense system by ozonized olive oil in DNBS-induced colitis in rats. Mediators of Inflammation 2014; 2014: 967205
  • 42 Griaham M. Oxidants and free radicals in inflammatory bowel disease. Lancet (British edition) 1994; 3444859-3444861
  • 43 Rapa SF, Waltenberger B, Di Paola R. et al. Plumericin prevents intestinal inflammation and oxidative stress in vitro and in vivo. The FASEB Journal 2020; 34: 1576-1590
  • 44 Sharma A, Parikh M, Shah H. et al. Modulation of Nrf2 by quercetin in doxorubicin-treated rats. Heliyon 2020; 6: e03803
  • 45 Younus H. Therapeutic potentials of superoxide dismutase. International Journal of Health Sciences 2018; 12: 88-93
  • 46 Kedika RR, Souza RF, Spechler SJ. Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Digestive Diseases and Sciences 2009; 54: 2312-2317
  • 47 Pulli B, Ali M, Forghani R. et al. Measuring myeloperoxidase activity in biological samples. PLoS One 2013; 8: e67976
  • 48 Khan AA, Alsahli MA, Rahmani AH. Myeloperoxidase as an active disease biomarker: Recent biochemical and pathological perspectives. Medical sciences (Basel, Switzerland) 2018; 6
  • 49 Roediger W. Nitric oxide damage to colonocytes in colitis-by-association: remote transfer of nitric oxide to the colon. Digestion 2002; 65: 191-195
  • 50 DS S, Sandhu DS, Fass R.. Current Trends in the Management of Gastroesophageal Reflux Disease. Gut and Liver 2018; 12: 7-16
  • 51 Zizzo MG, Caldara G, Bellanca A. et al. Preventive effects of guanosine on intestinal inflammation in 2, 4-dinitrobenzene sulfonic acid (DNBS)-induced colitis in rats. Inflammopharmacology 2019; 27: 349-359
  • 52 Wéra O, Lancellotti P, Oury C. The dual role of neutrophils in inflammatory bowel diseases. Journal of Clinical Medicine 2016; 5: 118
  • 53 Seril DN, Liao J, Yang GY. et al. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 2003; 24: 353-362
  • 54 Barazzone C, White CW. Mechanisms of cell injury and death in hyperoxia: Role of cytokines and Bcl-2 family proteins. American Journal of Respiratory Cell and Molecular Biology 2000; 22: 517-519
  • 55 Xing J-F, Sun J-N, Sun J-Y. et al. Protective effects of 3, 4-oxo-isopropylidene-shikimic acid on experimental colitis induced by trinitrobenzenesulfonic acid in rats. Digestive Diseases and Sciences 2012; 57: 2045-2054
  • 56 Pulli B, Ali M, Forghani R. et al. Measuring myeloperoxidase activity in biological samples. PLoS One 2013; 8: e67976
  • 57 Yue G, Lai PS, Yin K. et al. Colon epithelial cell death in 2, 4, 6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production. Journal of Pharmacology and Experimental Therapeutics 2001; 297: 915-925